---
schema_version: "secwatch.filing_event.v1"
accession: "0001014739-22-000006"
form_type: "8-K"
ticker: "OPCH"
cik: "0001014739"
company_name: "Option Care Health, Inc."
filed_at: "2022-02-23T23:59:59+00:00"
generated_at: "2026-06-27T05:14:25.477145+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Option Care Health Q4 revenue up 15.2% to $927M; EPS $0.42; two acquisitions

## Summary
- Q4 revenue $927.2M (+15.2%); net income $75.5M ($0.42 EPS incl. $0.17 one-time tax benefit) vs $17.8M ($0.10) prior year.
- Full-year 2021 revenue $3,438.6M (+13.4%); net income $139.9M ($0.78 EPS) vs. loss of $8.1M in 2020.
- Adjusted EBITDA Q4 $86.8M (+28.3%); full-year $289.8M (+30.7%); operating cash flow $208.6M (+63.7%).
- Acquired Infinity Infusion ($50M) and Wasatch ($17.8M) in Dec 2021; entered definitive agreement to acquire SPNN in 2022.
- FY 2022 guidance: revenue $3.65B-$3.85B; adjusted EBITDA $310M-$330M; operating cash flow ≥$230M.

## SEC filing metadata
- accession: 0001014739-22-000006
- form_type: 8-K
- ticker: OPCH
- cik: 0001014739
- company_name: Option Care Health, Inc.
- filed_at: 2022-02-23T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1014739/000101473922000006/0001014739-22-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1014739/000101473922000006/bios-20220223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001014739-22-000006
- JSON: https://secwatch.observer/filing/0001014739-22-000006.json
- Plain text: https://secwatch.observer/filing/0001014739-22-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.